BILIARY ALBUMIN EXCRETION INDUCED BY BILE-SALTS IN RATS IS A PATHOLOGICAL PHENOMENON
- 1 September 1989
- journal article
- research article
- Vol. 65 (3) , 373-388
Abstract
The bile to plasma 125I-albumin concentration ratio (B/P ratio) was examined before and during various bile salt infusions in male Wistar rats that had previously received iv injection of 125I-albumin. Endogenous rat albumin and IgG concentrations in the bile were also determined by a single radial immunodiffusion method. Taurocholate (TC) infusion (1.0 .mu.mol/min/100 g body wt) significantly increased the bile flow rate in the first hr but the flow began to decline in the second hr. The B/P ratio as well as rat albumin (and IgG) excretion into the bile significantly increased as early as 15 min after the start of TC infusion, and the increase became more pronounced in the second hr, when the bile flow began to decrease. Infusion of taurochenodeoxycholate (TCDC, 0.4 .mu.mol/min/100 g) caused a reduction in bile flow 15 min after the start of infusion but the B/P ratio increased 40 times at its peak compared with the basal value before the bile salt infusion. Simultaneous infusion of tauroursodeoxycholate (TUDC, 0.6 .mu.mol/min/100 g) and TCDC not only abolished the cholestasis induced by TCDC but maintained stable choleresis as long as for 2 hr. During this choleretic period, the B/P ratio never exceeded the basal value. The choleresis induced by either taurodehydrocholate (TDHC) or bucolome was not accompanied by enhanced albumin excretion. In rats given TDHC infusion, albumin excretion started to increase only after the bile flow began to decline following the intial choleretic period. The enhanced excretion of albumin induced by TC and TCDC is therefore suggested to be caused not by the choleresis per se but by a possible concomitant increase in the communication between sinusoids and bile canaliculi, which eventually leads to cholestasis. Our results suggest that the biliary excretion of albumin enhanced by bile salt infusion in rats is primarily the result of hepatocyte damage closely related to cholestasis rather than to choleresis, and that the rate of such excretion can be used as a convenient and reliable marker for hepatocyte damage.This publication has 11 references indexed in Scilit:
- IS URSODEOXYCHOLIC ACID AN EFFECTIVE TREATMENT FOR PRIMARY BILIARY CIRRHOSIS?The Lancet, 1987
- Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-upDigestive Diseases and Sciences, 1985
- Tauroursodeoxycholate prevents biliary protein excretion induced by other bile salts in the ratAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1985
- Intracellular and transcellular transport of secretory component and albumin in rat hepatocytes.The Journal of cell biology, 1983
- INTERACTIONS BETWEEN DIFFERENT BILE-SALTS IN THE BILIARY-EXCRETION OF THE RAT1983
- Selective transport of polymeric immunoglobulin A in bile. Quantitative relationships of monomeric and polymeric immunoglobulin A, immunoglobulin M, and other proteins in serum, bile, and saliva.Journal of Clinical Investigation, 1982
- Tauroursodeoxycholate prevents taurocholate induced cholestasisLife Sciences, 1982
- Difference in the effect of bucolome on the hepatic transport maximum of sulfobromophthalein and indocyanine green.The Tohoku Journal of Experimental Medicine, 1978
- The biliary excretion of bucolome in the rat: A possible cause for choleresisBiochemical Pharmacology, 1977
- Bile-salt-dependent and independent choleresis induced by bucolome in the ratCanadian Journal of Physiology and Pharmacology, 1977